Future-ready comprehensive cancer alliance
In our complex world, where knowledge and information are immediate and global, it pays to share.
With very evident support from public and private funding sources, there is optimism that 2021 will usher in a new era of cancer research and development, teamed with commercial collaboration, and a whole-of-Victoria desire to improve cancer outcomes globally.
The right drug to the right patient at the right time
The principle of precision oncology is to give the right drug to the right patient at the right time by using genomic profiling of the tumour to guide treatment. While next-generation genome sequencing technologies are increasingly used in clinical research and to select patients for clinical trials, they are not yet well integrated into routine clinical practice.
VCCC Nurse-led Research Hub finds global audience
Professor Meinir Krishnasamy, the lead of VCCC Nurse-led Research Hub (the Hub), co-chaired the GAP2020 conference nursing concurrent session with Patricia Johnston Executive Director, MD Anderson. Mei spoke about the multi-dimensional approach taken to the development and delivery of the Hub and presented evidence of its success and impact.
Second annual consumer engagement forum
The second annual consumer engagement forum on Wednesday 9 December, hosted by the VCCC Cancer Consumer Advisory Committee (CCAC) brought together consumers and researchers in equal numbers, as well as those who support these working relationships.
With over 80 per cent of the participants having existing experience, the forum set out to explore ways to enhance consumer integration into research practice, by sharing practical ideas and exemplar case studies.
Cancer sector response to COVID-19 becomes enduring collaborative network
In March 2020, the VCCC alliance and Monash Partners Comprehensive Cancer Consortium joined forces to create the Victorian COVID-19 Cancer Network (VCCN). As a workforce-led initiative, this provided an agile cancer sector response to the rapidly evolving issues created by the COVID-19 pandemic which affected everything from treatment guidelines to staff wellbeing.
Master of Cancer Sciences
The inaugural class of the Master of Cancer Sciences from the University of Melbourne and Victorian Comprehensive Cancer Centre has completed the groundbreaking new course.
Demand has grown since the first intake of 33 students two years ago, with 184 currently enrolled in a Graduate Certificate, Specialist Certificate or Master’s pathway. The new graduates represent a broad range of disciplines from oncology, neurosurgery, nursing, allied health, pharmacy, dentistry, research and clinical trials.
Researchers: complete survey for a chance at $50 gift-card
A new IIT Toolkit was created in 2020. The toolkit is accessible via the VCCC website and provides the Victorian clinical trials sector with a one-stop-shop to understanding and implementing an investigator-initiated trial.
Toolkit users are invited to complete a short survey, taking around five minutes to identify how the toolkit can be further developed and improved.
Annual colloquium for The Lorenzo and Pamela Galli Medical Research Trust
Due to Victoria’s COVID-19 restrictions, the colloquium – like many events in 2020 – went online. But distance couldn’t detract from the transformative research made possible by The Lorenzo and Pamela Galli Medical Research Trust.
The colloquium puts a spotlight on research projects currently receiving support from The Lorenzo and Pamela Galli Medical Research Trust and celebrates their progress. Established in 2017 by Pamela Galli AO, the Trust is uniquely designed to empower collaborative research between four institutions – the University of Melbourne, the Peter MacCallum Cancer Centre, WEHI and the Royal Children’s Hospital – in the areas of developmental disorders and cancer.